Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)
doi: 10.3389/fimmu.2024.1497522 57 Kewitz-HempelSWindischNHauseGMllerLSunderktterCGerloffD
These studies, even in diabetic conditions (Seveljevic-Jaran et al., 2006
Most gastrointestinal events were classified as mild to moderate, and the majority were transient, resolving within the first several weeks of treatment or after dose stabilization
US$ 25.87
US$ 20.02
US$ 23.75
US$ 24.20
US$ 21.93
